Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies.
about
Intra-arterial chemoradiotherapy for head and neck cancerCurative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year resultsAUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity.A new method for repeated drug infusion into the femoral artery of mice.Targeted infusions of supradose Cisplatin with systemic neutralization for carcinomas invading the temporal boneIntraarterial chemotherapy as the first-line therapy in penile cancerMarkers of chemoradiation resistance in patients with locally advanced head and neck squamous cell carcinoma, treated by intra-arterial carboplatin and concurrent radiationConcurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term resultsSystemic treatment of locally advanced nonmetastatic cutaneous squamous cell carcinoma: a review of the literature.Effectiveness of superselective intra-arterial chemoradiotherapy targeting retropharyngeal lymph node metastasis.Targeted nanoparticle for head and neck cancers: overview and perspectives.Highly selective infusions of supradose Cisplatin for cranial base malignancies.Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer.Cerebral infarction after intraarterial and intravenous chemoradiotherapy for head and neck cancer: A retrospective analysis using a Japanese inpatient database.Treatment Outcomes of Locally Advanced Squamous Cell Carcinoma of the Ethmoid Sinus Treated with Anterior Craniofacial Resection or Chemoradiotherapy.Statistical analysis of surgical site infection after head and neck reconstructive surgery.Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment.Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.A Novel External Carotid Arterial Sheath System for Intra-arterial Infusion Chemotherapy of Head and Neck Cancer.Primary gingival angiosarcoma successfully treated by radiotherapy with concurrent intra-arterial chemotherapy.Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.Selective intraarterial chemoradiation therapy for oropharyngeal carcinoma with high-dose cisplatin.Feasibility and safety of transfemoral intra-arterial chemotherapy for head and neck cancer using a 3-French catheter system: comparison with a 4-French catheter system.Efficacy of concurrent superselective intra-arterial chemotherapy and radiotherapy for late-stage squamous cell carcinoma of the temporal bone.Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility TrialA new combined therapy for functional organ preservation and survival in lateral oropharyngeal wall cancerComparative Study of Superselective Intra-Arterial Chemoradiotherapy versus Radical Surgery on Distant Metastasis for Advanced Oral Cancer
P2860
Q26781184-4AB95BFC-B912-4483-B787-0C52AE66E180Q33281828-A201B9E0-738D-4098-915A-2A44B0E53B89Q33360837-EBA3AADB-9231-446A-8E0F-07AADE1B8745Q34538204-A32F99D1-3D73-4112-8E13-E9B807CC009DQ35160763-21ED5E8A-E886-4106-A85F-B0DFB166135CQ35678387-328BB82B-8E0A-432A-A814-FCE1DA8858BCQ37092118-AFA4F0ED-FCAC-4953-A48A-63C2960D1367Q37357981-1552DCC9-8713-43F1-9A97-401A5BAA2028Q37903371-DDEDA156-EBBE-4C68-8291-3A0EA62BC12FQ38732532-EBA7C493-50B3-4DFC-8DDB-9D5A098A2345Q39226270-38B135E8-CAF5-4649-8788-AA1B2FE5802AQ39891596-B7EDA807-036E-477D-8BE4-475A0524C6A3Q40155495-1E4457F5-5AFB-459E-A61D-5EE935D196DDQ40832963-0EA0BBE0-3BE5-4403-8AFA-CEA044D6F62BQ42258944-6AAA2A3D-A464-4891-8DA8-C9B25BB6535DQ43825022-6D3CA526-2815-4617-A55A-734A2E23719CQ44468905-6869E7BB-8906-4975-B4F8-4F0EFFACFCB1Q44504104-AB0A06BD-43E8-4A47-9826-BBECD356D3CFQ44718510-A5E18E5F-66F9-4830-B759-388FEE3EDE95Q45251953-C2852822-D041-48CE-9F74-C91814A36B97Q48346161-B8099A52-B78E-45E6-8CE5-34BBB28B1FFFQ51531328-379D2683-B13C-4C54-9566-3653E4AC3F91Q52147148-A32A5054-82D4-4BF8-B78E-13DE6DBBC1A3Q52984081-E729E416-2756-4EBB-B79D-FDC75BCBAE9DQ53201937-20C9D05C-7C55-4089-A95E-1AA98755CF17Q53246466-648C9358-81BE-4EDC-8ED4-5FAB28A0688CQ54186648-07CE14FB-20E1-46FC-84A6-1961B21D6EAAQ57824720-8E98F545-EA91-4124-9D7E-109E3E7C08D0Q58170487-49769282-C2D5-4DD6-AF33-D5CD62552B3FQ59048840-530EDFA1-844F-4923-A42B-AC41D570481C
P2860
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Rapid superselective high-dose ...... ed head and neck malignancies.
@en
Rapid superselective high-dose ...... ed head and neck malignancies.
@nl
type
label
Rapid superselective high-dose ...... ed head and neck malignancies.
@en
Rapid superselective high-dose ...... ed head and neck malignancies.
@nl
prefLabel
Rapid superselective high-dose ...... ed head and neck malignancies.
@en
Rapid superselective high-dose ...... ed head and neck malignancies.
@nl
P2093
P356
P1433
P1476
Rapid superselective high-dose ...... ed head and neck malignancies.
@en
P2093
P304
P356
10.1002/HED.2880140505
P577
1992-09-01T00:00:00Z